Navigation Links
Tolerx Presents Preclinical Data on Novel T-cell Modulator, TRX518, for Antitumor Immune Response at Federation of Clinical Immunology Societies Scientific Meeting
Date:6/25/2010

encouraged by the preclinical results with anti-GITR immunotherapy. This approach appears to induce unique mechanisms for augmenting antitumor immune responses and holds promise for treating malignancies in man," said Louis Vaickus, MD, Chief Medical Officer at Tolerx. "In a murine model of established colon cancer, the results, especially the complete remissions, were striking and these findings represent preclinical proof of concept for TRX518."

About TRX518

TRX518 is a targeted T-cell immunomodulator that binds to the glucocorticoid-induced tumor necrosis factor receptor (GITR) found on multiple types of T cells and other immune cells. Activated GITR plays a role in directing the antitumor immune response via activating tumor-antigen-specific T effector cells, as well as abrogating the suppression induced by inappropriately activated T regulatory cells. In preclinical studies, TRX518 achieved its targeted effect without compromising normal immune function and preclinical models suggest TRX518 may have a reduced risk of causing the serious inflammatory side effects that can result from cytokine release.

About Tolerx

Tolerx, Inc., a world leader in the understanding of T cell function, is developing novel therapies intended to treat autoimmune diseases, diabetes, and cancer by specifically modulating T cell activity. The company's pipeline includes its lead candidate, otelixizumab, a targeted T cell immunomodulator in Phase 3 development for the treatment of type 1 diabetes that is partnered with GlaxoSmithKline. TRX1, a Phase 1 candidate, is a nonlytic anti-CD4 antibody that is being developed for the treatment of aberrant or untoward immune responses. The company also has three preclinical candidates, TRX518, TRX585, and TRX385, which enhance immune responses and as such are being evaluated
'/>"/>

SOURCE Tolerx, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
2. Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial
3. Tolerx Announces Achievement of Milestones upon anti-CD4 Antibody Program Advancement and Initiation of Phase 1 Clinical Trial
4. Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting
5. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
6. Lexicon Presents Data Describing LX4211 Positive Phase 2 Clinical Results and Novel Mechanism of Action for Type 2 Diabetes
7. Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
8. Lilly Presents New Data in Advanced Melanoma - A Difficult-To-Treat Cancer That Causes Majority of Skin Cancer Deaths
9. Mpex Pharmaceuticals Presents Positive Phase 2 Clinical Trial Results of Aeroquin(TM) (MP-376) Treatment in Cystic Fibrosis Patients
10. Spectros Presents at the Pediatric Academic Societies (PAS) National Conference 2010
11. Lexicon Presents Positive Outcome in IBS Patients Treated With LX1031 and Data Supporting Mechanism of Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the ... acquired Polaris Medical Imaging, a leader in sales, service ... strategic acquisition allows BC Technical to continue to expand ... within MR and CT modalities. "We ... said Mark Alvarez , president and CEO of ...
(Date:8/29/2014)... Research and Markets  has announced the addition of the ... to their offering. The Central Nervous System ... segments of pharmaceuticals industry. The numbers of CNS disorders have ... unable to meet the market requirements. There has been steady ... over the past two decades. The market for CNS therapies ...
(Date:8/29/2014)... Research and Markets has announced ... Forecast of Pharmaceutical Equipment Market in China, 2014-2018" ... Development Trend Forecast of Pharmaceutical Equipment Market in ... China,s pharmaceutical equipment industry in the aspects ... and business performance of domestic major enterprises, as well ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2US CNS Disorders Drug Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... May 20 The owner and operator of a Houston-area ... program, announced the Departments of Justice and Health and Human Services (HHS). ... William M. ... fraud before U.S. District Judge David Hittner in U.S. District ...
... May 20 Inverness Medical Innovations, Inc. (NYSE: ... charge of their health at home through the merger of rapid ... Citi Global Health Care Conference being held May 26 through ... New York City .  Jon Russell, Vice President, Finance, will attend. ...
Cached Medicine Technology:Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 2Houston-Area Durable Medical Equipment Company Owner Pleads Guilty to Fraud Scheme Involving Nutrition Supplies 3
(Date:9/2/2014)... 02, 2014 Request A Test , a ... a 10% discount on all drug testing in September ... need to use promo code DRUG10 when placing their order. ... blood and hair. Drug testing is typically done in panels ... of the most popular panels include the 5 Panel Urine ...
(Date:9/2/2014)... 02, 2014 Michigan’s health care landscape ... Act and the Healthy Michigan Plan. Throughout these changes, ... a trusted funding resource for under-served individuals. Federal and ... or underinsured women between the ages of 50 and ... percent of the federal poverty level. , ...
(Date:9/2/2014)... ZAMST, a leader in high-performance sports prevention/protective ... baseball star Nolan Arenado . Widely considered ... Arenado will be working with Zamst to continue their ... , Arenado was selected by Colorado in the second ... Arenado was awarded the Gold Glove, putting him among ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 Recently, Os-Monitor.com, ... programs, has announced its new collection of employee internet ... is now providing big discounts, up to 10% off, ... company is now selling more than 20 different kinds ... of them are very useful for companies of all ...
(Date:9/2/2014)... San Diego, CA (PRWEB) September 02, 2014 ... kicking coach Anthony Cantele of Cantele Kicking on his role ... a National Camp Series (NCS) Associate according to retired ... a great career at Kansas State University and is one ... Husted. “I had a chance to meet with Anthony at ...
Breaking Medicine News(10 mins):Health News:Request A Test Offers 10% Off Drug Testing in September 2014 2Health News:Request A Test Offers 10% Off Drug Testing in September 2014 3Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 2Health News:Local Affiliate of National Health Organization Continues 16-Year Tradition of Funding Programs to Help Fill Gaps in Breast Health Services for Under-Served Populations 3Health News:Gold Glove Baseball Star Nolan Arenado Signs With Zamst 2Health News:Useful Employee Internet Monitoring Products Now For Sale At Os-Monitor.com 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 3
... , THURSDAY, May 12 (HealthDay News) -- Music ... finding of a study by Northwestern University researchers who compared ... "Lifelong musical training appears to confer advantages in at ... memory and the ability to hear speech in noise," study ...
... inhalers may increase a smoker,s chance of quitting, according to ... . This study is the first to assess ... smoking. The research, which was carried out by ... people who were enrolled in a programme to help them ...
... , WEDNESDAY, May 11 (HealthDay News) -- Autism takes ... underemployment and lost income among mothers, University of Pennsylvania ... for a child with autism, however high, are only ... on families should be considered whenever policymakers fund autism ...
... a patient,s knowledge of family medical history to estimate his ... cancer history are not highly accurate, according to a study ... the National Cancer Institute. Primary care physicians ... screening or referrals to specialists, for instanceon the results. ...
... also known as Lou Gehrig,s disease, may be an exception ... In a retrospective study of over 400 ALS patients, ... mildly obese survived longer than patients who were normal weight, ... the journal Muscle & Nerve and has been published online. ...
... (HealthDay News) -- Among teen boys with an autism ... with a greater degree of bullying behavior than their ... observation specifically reflects upon boys aged 12 to 18, ... intimidation, rumor-mongering and group exclusion that characterize bullying behavior. ...
Cached Medicine News:Health News:Musicians Maintain Memory, Hearing as They Age 2Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 2Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 3Health News:Autism Takes an Economic Toll on Mom's Job, Income: Study 4Health News:Patient reports of relatives' cancer history often not accurate 2Health News:Mild obesity appears to improve survival in ALS patients 2Health News:Teen Boys With Autism at Risk of Being Bullied: Study 2
... design includes several innovative features ... coating option for stable fixation ... bone preserving posterior stabilizing design, ... maximize range of motion, simple ...
Consensus Knee implants are designed to provide both joint and implant stability and allow near normal kinematics. The components are anatomic with porous and nonporous options. Six femoral/tibial an...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively....
... Duracon tibial inserts have radiused A/P ... 4-axis machining, maximizing conformity of the ... of the femoral component. The resulting ... Duracon system, and accommodates the knee's ...
Medicine Products: